QuidelOrtho (QDEL) Change in Accured Expenses (2021 - 2026)

QuidelOrtho (QDEL) has 6 years of Change in Accured Expenses data on file, last reported at $15.7 million in Q1 2026.

• For the quarter ending Q1 2026, Change in Accured Expenses fell 7.65% year-over-year to $15.7 million; the trailing twelve-month figure through Mar 2026 stood at -$400000.0 (down 101.52% YoY), and the FY2025 full-year result was $900000.0, down 97.43% from the prior year.
• Change in Accured Expenses slipped to $15.7 million in Q1 2026, from $15.8 million in the prior quarter.
• In the past five years, Change in Accured Expenses ranged from a high of $52.9 million in Q4 2023 to a low of -$79.5 million in Q2 2024.
• A 5-year average of -$2.5 million and a median of $15.7 million in 2026 frame the typical range for Change in Accured Expenses.
• Peak annual rise in Change in Accured Expenses reached 2622.22% in 2024, while the deepest fall reached 190.15% in 2024.
• Tracing QDEL's Change in Accured Expenses over 5 years: stood at -$12.2 million in 2022, then surged by 85.25% to -$1.8 million in 2023, then surged by 2622.22% to $45.4 million in 2024, then sank by 65.2% to $15.8 million in 2025, then dropped by 0.63% to $15.7 million in 2026.
• Business Quant data shows QDEL's Change in Accured Expenses at $15.7 million in Q1 2026, $15.8 million in Q4 2025, and $20.0 million in Q3 2025.